Dachaigh › Leukemia Lymphocytic Cronach › Texas › Houston
Sgrùdaidhean clionaigeach Leukemia Lymphocytic Cronach ann an Houston, TX
Tha 17 sgrùdaidhean airson Leukemia Lymphocytic Cronach a’ lorg phàirtichean aig làraichean ann agus timcheall air Houston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
A’ fastadhÌre 1
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- UT MD Anderson Cancer Center, Houston
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
A’ fastadhÌre 1/2
- Research Site, Houston
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
A’ fastadhÌre 1/2
- Md Anderson Cancer Center, Houston
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A’ fastadhÌre 3
- Md Anderson Cancer Center, Houston
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
A’ fastadhÌre 3
- The University of Texas MD Anderson Cancer Center, Houston
Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A’ fastadhÌre 2
- M D Anderson Cancer Center, Houston
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
A’ fastadhÌre 1/2
- Research Site, Houston
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
A’ fastadhÌre 1/2
- MD Anderson, Houston
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
A’ fastadhÌre 1/2
- University of Texas MD Anderson Cancer Center, Houston
Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).
A’ fastadhÌre 2
- MD Anderson Cancer Center, Houston
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
A’ fastadhÌre 1
- MD Anderson Cancer Center, Houston
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
A’ fastadhÌre 1
- MD Anderson Cancer Center, Houston
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
A’ fastadhÌre 1
- MD Anderson Cancer Center, Houston
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
A’ fastadhÌre 4
- University of Texas MD Anderson Cancer Center, Houston
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
A’ fastadhÌre 4
- University of Texas MD Anderson Cancer Center, Houston
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
A’ fastadhÌre 1
- Oncology Consultants, Houston
- University of Texas MD Anderson Cancer Center, Houston
Sgrùdaidhean Leukemia Lymphocytic Cronach ann am bailtean eile
- Boston, MA31 sgrùdaidhean
- Columbus, OH28 sgrùdaidhean
- Durham, NC27 sgrùdaidhean
- Washington, DC22 sgrùdaidhean
- Seattle, WA20 sgrùdaidhean
- Rochester, MN19 sgrùdaidhean
- New York City, NY18 sgrùdaidhean
- Baldwin Park, CA16 sgrùdaidhean
- Milwaukee, WI15 sgrùdaidhean
- Cincinnati, OH14 sgrùdaidhean
- Chicago, IL14 sgrùdaidhean
- Nashville, TN13 sgrùdaidhean
Sgrùdaidhean eile ann an Houston
- Aillse Sgamhain Neo-chealla-beag145 sgrùdaidhean
- Aillse a' bhroilleach126 sgrùdaidhean
- Aillse (gach seòrsa)121 sgrùdaidhean
- Ailse metastatach104 sgrùdaidhean
- Aillse colorectal102 sgrùdaidhean
- Cancer Ovarian89 sgrùdaidhean
- Leukemia myeloid geur85 sgrùdaidhean
- Ailseachadh nan Sgamhan78 sgrùdaidhean
- Aillse Prostata76 sgrùdaidhean
- Ailse Endometrial68 sgrùdaidhean
- Cancer Pancreatic61 sgrùdaidhean
- Melanoma59 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.